MIRSX | VMVAX | MIRSX / VMVAX | |
Total Expense Ratio | 0.83 | 0.07 | 1,186% |
Annual Report Gross Expense Ratio | 0.94 | 0.07 | 1,343% |
Fund Existence | 11 years | 14 years | - |
Gain YTD | 8.032 | 6.882 | 117% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 346M | 32B | 1% |
Annual Yield % from dividends | 1.00 | 2.15 | 46% |
Returns for 1 year | 2.31 | 7.20 | 32% |
Returns for 3 years | 16.58 | 29.26 | 57% |
Returns for 5 years | 63.70 | 67.70 | 94% |
Returns for 10 years | 89.53 | 101.90 | 88% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MSEGX | 64.30 | 0.80 | +1.26% |
Morgan Stanley Inst Growth A | |||
GSMVX | 17.12 | 0.07 | +0.41% |
Goldman Sachs Small/Mid Cap Equity Instl | |||
RGAHX | 85.13 | 0.20 | +0.24% |
American Funds Growth Fund of Amer R5E | |||
RGPAX | 23.27 | 0.02 | +0.09% |
RBC Global Opportunities A | |||
AWAAX | 23.95 | -0.03 | -0.13% |
AB Wealth Appreciation Strategy A |